Ir para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Palavra solta
Título
Autor
Assunto
Área/Cota
ISBN/ISSN
Tag
Pesquisar
Avançada
Cetuximab plus Irinotecan as t...
Citar
Enviar por SMS
Enviar por email
Imprimir
Exportar registo
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Permanent link
Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer
Detalhes bibliográficos
Main Authors:
Moe, M
,
Micallef, R
,
Pwint, T
,
Maughan, T
,
Mort, D
,
Wagstaff, J
Formato:
Journal article
Publicado em:
2008
Exemplares
Descrição
Registos relacionados
Registo fonte
Registos relacionados
Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis
Por: Meysam Seyedifar, et al.
Publicado em: (2024-10-01)
EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
Por: Frifeldt Sanne K, et al.
Publicado em: (2011-03-01)
Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
Por: Maria Ignez Freitas Melro Braghiroli, et al.
Publicado em: (2024-01-01)
Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
Por: Adams, R, et al.
Publicado em: (2008)
First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
Por: Yu‐Wen Zhou, et al.
Publicado em: (2021-05-01)